Navigation Links
NeurogesX Closes $25 Million Private Placement
Date:1/9/2008

SAN MATEO, Calif., Jan. 9 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX), a biopharmaceutical company focused on developing novel pain management therapies, today announced that it completed a $25.0 million private placement of its common stock to support the development of its late stage portfolio of novel pain management therapies.

On December 26, 2007, the Company announced that on Sunday, December 23, 2007, it entered into a securities purchase agreement in connection with a private placement to a group of institutional accredited investors. In the closings, which occurred on December 26 and January 3, the Company received approximately $25 million in gross proceeds from the sale of 4,020,910 shares of its common stock at a purchase price of $6.18 per share, the last closing price prior to signing of NGSX common stock on the NASDAQ Global Market, and the issuance of five-year warrants to purchase 1,206,273 additional shares of NGSX common stock at an exercise price of $8.034 per share. The warrants were purchased at a price per underlying share of $0.125.

The financing was led by SV Life Sciences, a life sciences-focused venture capital adviser and manager. SV Life Sciences advised or managed funds invest in companies requiring funding within the human life sciences sector including biotechnology and pharmaceuticals, medical devices and instruments, healthcare IT and services. SV Life Sciences advises or manages four venture capital funds and a publicly traded investment trust with total capital of approximately $1.6 billion that invest in life sciences companies at all stages of development. Bruce Peacock, a venture partner at SV Life Sciences, has served as an independent director of NeurogesX, Inc. since Aug
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NeurogesX, Inc. Announces $25 Million Private Placement
2. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
3. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. NeurogesX Expands Senior Management Team
5. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
6. NeurogesX Appoints New Director to the Board
7. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
8. AspenBio Pharma Closes $18.2 Million Private Placement of Common Stock
9. Senesco Technologies Closes on Additional $4.0 Million of Previously Announced Financing
10. Helix BioPharma closes $16.9 million private placement of common shares
11. The closest look ever at native human tissue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... R.I. (Brown University) -- The discovery 30 years ago ... an explosion of nanotechnology research. Now, there appears to ... from Brown University, Shanxi University and Tsinghua University in ... atoms forms a hollow molecular cage similar to a ... boron cage structurepreviously only a matter of speculationdoes indeed ...
(Date:7/13/2014)... Dallas, TX (PRWEB) July 13, 2014 ... Silver Industryā€¯ is a professional and in-depth study on ... Global and China. , The report provides a basic ... chain structure. Global market analysis and Chinese domestic market ... trends and competitive landscape of the market. A comparison ...
(Date:7/12/2014)... York (PRWEB) July 12, 2014 ... for various reagents used in the life ... driving the life science reagents market towards ... include manufacturers and providers of life science ... Market Report: http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html . , The ...
(Date:7/11/2014)... July 11, 2014 /PRNewswire-iReach/ -- Maxim Peptide, a website ... are used solely in scientific experiments, is currently celebrating ... in business, Maxim Peptide, which was created by the ... new and updated website that now features a special ... been updated with fascinating articles about peptide research, including ...
Breaking Biology Technology:Researchers discover boron 'buckyball' 2Researchers discover boron 'buckyball' 32014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 2Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 3Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2
... Neurognostics , a home-grown Milwaukee medical device company, ... the first to take advantage of Wisconsin's new tax credits ... of an investment. , ,Neurognostics oversubscribed on its $1 million ... CEO af Neurognostics. As a tech-based research and development company, ...
... produce a single venture capital deal from January through March ... , ,Venture capitalists in the state said that the lack ... the state, though it is another reminder that capital is ... Wisconsin's investments have come erratically, sometimes adding up to around ...
... enough. Researchers at the University of Wisconsin-Madison, among other ... networked computers that share tasks such as analyzing the ... Schwartz are working with the Grid Laboratory of ... system used is Condor, software developed in-house to grab ...
Cached Biology Technology:Milwaukee firm among first to use Act 255 tax credits in investor pitch 2Milwaukee firm among first to use Act 255 tax credits in investor pitch 3Milwaukee firm among first to use Act 255 tax credits in investor pitch 4Money Tree survey shows lull in Wisconsin venture capital deals 2Money Tree survey shows lull in Wisconsin venture capital deals 3
(Date:7/13/2014)... in French . ... research project, led by the Research Institute of the ... a new oral medication is showing significant progress in ... Until now, this inherited retinal disease that causes visual ... remained untreatable. The study is published today in the ...
(Date:7/13/2014)... the prospect of more effective treatments for cachexia, a ... half of all cancer patients, raising their risk of ... Many strategies have been tried to reverse the condition, ... potentially life-saving treatments, but none have had great success. ... edition of Nature , led by Bruce Spiegelman, ...
(Date:7/11/2014)... from the Wildlife Conservation Society shows that no-take ... valuable species such as lobster, conch, and fish ... nearby reef areas. , The reporttitled "Review of ... of research literature from no-take areas around the ... Dahlgren, a recognized expert in marine protected areas ...
Breaking Biology News(10 mins):MUHC researcher unveils novel treatment for a form of childhood blindness 2Antibody halts cancer-related wasting condition 2Antibody halts cancer-related wasting condition 3Belize's lobster, conch, and fish populations rebuild in no-take zones 2
... critical cellular activities in plants and animals by using ... to learn from nature, a team of Northwestern University ... Air Force Office of Scientific Research to study and ... civilian applications. The grant is part of the ...
... Marine Animal Population , Edited by David J. ... http://shop.earthscan.co.uk/ProductDetails/mcs/productID/821 , Violent confrontations on the ... the intense hunt for sponges on Floridas fragile coral ... sponges themselves. Human harvesters not only depleted the sponge ...
... elderly residents and giving them fewer sleeping pills could ... nursing home units published in the January issue of ... by the Karolinska Institutet, Sweden, analysed 2,343 reported falls ... how they related to fall risk assessments and the ...
Cached Biology News:Team of chemists receives $5 million grant to develop enzyme mimics 2Oceans Past: A Guide to Oceans Future 2Oceans Past: A Guide to Oceans Future 3Oceans Past: A Guide to Oceans Future 4Oceans Past: A Guide to Oceans Future 5Oceans Past: A Guide to Oceans Future 6Selective restraints and reduced medication could reduce nursing home falls says 4-year study 2
PCR System for increased fidelity, yield and length of PCR products. Amplifies targets up to 10 kb from human genomic DNA....
Immunogen: Heat inactivated bacterial cells of Salmonella enteriditis,paratyphi and typhimurium Storage: 4 C...
... Immunogen: Recombinant protein ... region of human ubiquilin. ... the human ubiquilin protein. ... control: 293 cells). ...
...
Biology Products: